BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapyHumansVaccine DevelopmentNanoparticlesDrug CarriersVaccines
Harnessing Nanocarriers to Advance Vaccine Development.
Hariz Mohamad Salleh, Farid Nazer Faruqu, Ajantha Sinniah, Pooi-Fong Wong
Published: 202610.1007/s40259-025-00759-5
Abstract
Nanocarriers (NCs) are nanosized delivery systems that can be engineered from lipids, polymers, inorganic compounds, viral structural proteins and extracellular vesicles to transport cargo efficiently. Their unique characteristics, including biocompa…
Preview only. Read the full abstract at the source